(Q32060426)

6 July 2017

A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity (English)

1 reference

6 July 2017

1 reference

Roberts SA

1

1 reference

PubMed ID

9635721

6 July 2017

Hendry JH

series ordinal

2

1 reference

PubMed ID

9635721

6 July 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

International Journal of Radiation Oncology Biology Physics

6 July 2017

1 reference

6 July 2017

41

1 reference

6 July 2017

3

1 reference

6 July 2017

689-699

1 reference

The steepness of the dose-response curve in radiation therapy. Theoretical considerations and experimental results

6 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

Dose-incidence curves for tumour control and normal tissue injury, in relation to the response of clonogenic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

Inter-tumor heterogeneity and radiation dose-control curves

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

The effect of patient-to-patient variability on the accuracy of predictive assays of tumor response to radiotherapy: a theoretical evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

Steepness of the Clinical Dose–control Curve and Variation in thein VitroRadiosensitivity of Head and Neck Squamous Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

Time-dose factors in radiotherapy: a review of the human data.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

Dose fractionation and tumour repopulation in radiotherapy for bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centres in Manchester, UK and Toronto, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

The influence of radiotherapy treatment time on the control of laryngeal cancer: a direct analysis of data from two British Institute of Radiology trials to calculate the lag period and the time factor

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

Local control of carcinoma of the tonsil by radiation therapy: An analysis of patterns of fractionation in nine institutions

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumour-control data

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

Radiosensitivity of human head and neck squamous cell carcinomas in primary culture and its potential as a predictive assay of tumor radiocurability

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: preliminary correlations with local control and overall survival

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

Tumor cell kinetics, local tumor control, and accelerated radiotherapy: a preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

In vivo measurement of the potential doubling time by flowcytometry in oropharyngeal cancer treated by conventional radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

Does Variation in thein VitroCellular Radiosensitivity Explain the Shallow Clinical Dose—control Curve for Malignant Melanoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

Volume and Heterogeneity Dependence of the Dose-Response Relationship for Head And Neck Tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

Tumour stem cells: the relevance of predictive assays for tumour control after radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

Final report on the second British Institute of Radiology fractionation study: short versus long overall treatment times for radiotherapy of carcinoma of the laryngo-pharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

Final report of the general clinical results of the British Institute of Radiology fractionation study of 3F/wk versus 5F/wk in radiotherapy of carcinoma of the laryngo-pharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

Comments on a time-dependent version of the linear-quadratic model

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

The clinical significance of ratios of radiobiological parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

Direct analysis of quantal radiation response data

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

Repopulation in the SCCVII squamous cell carcinoma assessed by an in vivo-in vitro excision assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

Improved models of tumour cure

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

How well is the probability of tumor cure after fractionated irradiation described by Poisson statistics?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

Clinical evidence for tumor clonogen regeneration: interpretations of the data.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

Time factor for tonsillar carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900100-X

7 January 2021

10.1016/S0360-3016(98)00100-X

Identifiers

DOI

1 reference

6 July 2017

1 reference

PubMed ID

9635721